Theriva Biologics(TOVX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TOVX Theriva Biologics

盘前交易 12-26 07:42:54 EST

1.76

+0.46

+35.38%

盘前1.59

-0.17-9.66%

07:40 EST

最高2.08	最低1.47	成交量685.75万
今开1.53	昨收1.30	日振幅46.92%
总市值489.71万	流通市值406.60万	总股本278.24万
成交额1,144万	换手率296.84%	流通股本231.02万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TOVX","market":"US","secType":"STK","nameCN":"Theriva Biologics","latestPrice":1.76,"timestamp":1735063200000,"preClose":1.3,"halted":0,"volume":6857527,"hourTrading":{"tag":"盘前","latestPrice":1.59,"preClose":1.76,"latestTime":"07:40 EST","volume":1472,"amount":2241.6200384,"timestamp":1735216851125},"delay":0,"floatShares":2310200,"shares":2782449,"eps":-31.5044,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.46,"latestTime":"12-26 07:42:54 EST","open":1.53,"high":2.08,"low":1.47,"amount":11438850.835202,"amplitude":0.469231,"askPrice":1.64,"askSize":100,"bidPrice":1.44,"bidSize":60,"shortable":3,"etf":0,"ttmEps":-31.5044,"exchange":"AMEX","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735223400000},"adr":0,"adjPreClose":1.76,"preHourTrading":{"tag":"盘前","latestPrice":1.59,"preClose":1.76,"latestTime":"07:40 EST","volume":1472,"amount":2241.6200384,"timestamp":1735216851125},"postHourTrading":{"tag":"盘后","latestPrice":1.48,"preClose":1.76,"latestTime":"16:59 EST","volume":151908,"amount":242084.2672,"timestamp":1735077571037},"volumeRatio":6.037641465228017},"requestUrl":"/m/hq/s/TOVX","defaultTab":"news","newsList":[{"id":"2493082712","title":"Theriva Biologics, Inc.盘中异动 股价大涨29.31%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493082712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493082712?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:33","pubTimestamp":1735050793,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时33分，Theriva Biologics, Inc.股票出现异动，股价大幅拉升29.31%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Clearmind Medicine Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.涨幅较大，Clearmind Medicine Inc.、180 Life Sciences Corp.、Theriva Biologics, Inc.较为活跃，换手率分别为899.86%、560.87%、102.12%，振幅较大的相关个股有Clearmind Medicine Inc.、Theriva Biologics, Inc.、Polyrizon Ltd.，振幅分别为21.30%、20.76%、17.90%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223313ab90ba6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223313ab90ba6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2493793332","title":"Theriva Biologics, Inc.盘中异动 快速拉升6.06%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493793332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493793332?lang=zh_cn&edition=full","pubTime":"2024-12-24 01:12","pubTimestamp":1734973954,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日01时12分，Theriva Biologics, Inc.股票出现波动，股价急速上涨6.06%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为903.45%、862.44%、821.54%，振幅较大的相关个股有Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.，振幅分别为157.37%、104.19%、96.28%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224011234a2055033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224011234a2055033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2491354063","title":"Theriva Biologics, Inc.盘中异动 下午盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491354063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491354063?lang=zh_cn&edition=full","pubTime":"2024-12-13 04:23","pubTimestamp":1734034980,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日04时23分，Theriva Biologics, Inc.股票出现波动，股价大幅上涨5.18%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为1.54%。其相关个股中，Palisade Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Trevi Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为4213.40%、1241.29%、96.39%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Aptevo Therapeutics Inc.，振幅分别为129.16%、99.29%、95.90%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213042300ab7342fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213042300ab7342fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2490668928","title":"Theriva Biologics, Inc.盘中异动 早盘大幅下挫6.20%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490668928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490668928?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:17","pubTimestamp":1733930243,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时17分，Theriva Biologics, Inc.股票出现异动，股价快速跳水6.20%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211231723984b5811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211231723984b5811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2489975450","title":"Theriva Biologics, Inc.盘中异动 早盘股价大跌6.04%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489975450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489975450?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:37","pubTimestamp":1733409477,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时37分，Theriva Biologics, Inc.股票出现异动，股价急速跳水6.04%。截至发稿，该股报1.26美元/股，成交量59.282万股，换手率21.31%，振幅3.06%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223757ab6000c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223757ab6000c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2488976440","title":"Theriva Biologics, Inc.盘中异动 临近收盘大幅下跌5.07%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488976440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488976440?lang=zh_cn&edition=full","pubTime":"2024-12-04 05:01","pubTimestamp":1733259689,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日05时01分，Theriva Biologics, Inc.股票出现波动，股价大幅跳水5.07%。截至发稿，该股报1.31美元/股，成交量7.586万股，换手率2.73%，振幅4.35%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120405013098e52b84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120405013098e52b84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2488608229","title":"Theriva Biologics, Inc.盘中异动 早盘大幅下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488608229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488608229?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:35","pubTimestamp":1733153756,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时35分，Theriva Biologics, Inc.股票出现波动，股价快速跳水5.56%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Senti Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Senti Biosciences, Inc.、Revelation Biosciences, Inc.、Cabaletta Bio, Inc.较为活跃，换手率分别为1730.88%、225.17%、24.22%，振幅较大的相关个股有Senti Biosciences, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为481.02%、64.17%、45.18%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202233556abf022d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202233556abf022d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2487649105","title":"Theriva Biologics, Inc.盘中异动 快速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487649105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487649105?lang=zh_cn&edition=full","pubTime":"2024-11-30 00:42","pubTimestamp":1732898531,"startTime":"0","endTime":"0","summary":"北京时间2024年11月30日00时42分，Theriva Biologics, Inc.股票出现波动，股价大幅上涨5.22%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Passage Bio, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Silo Pharma, Inc.、Klotho Neurosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为177.55%、71.12%、66.67%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为130.29%、105.44%、68.75%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130004211a25fb42b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130004211a25fb42b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2486730568","title":"Theriva Biologics, Inc.盘中异动 早盘急速上涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486730568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486730568?lang=zh_cn&edition=full","pubTime":"2024-11-27 23:26","pubTimestamp":1732721198,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日23时26分，Theriva Biologics, Inc.股票出现波动，股价急速上涨6.25%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Cyclerion Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为930.17%、82.97%、25.42%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Briacell Therapeutics Corp C/Wts 24/02/2025、Cyclerion Therapeutics, Inc.，振幅分别为52.60%、35.46%、34.56%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127232638971a8e8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127232638971a8e8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2484920057","title":"Theriva Biologics, Inc.盘中异动 股价大涨5.65%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484920057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484920057?lang=zh_cn&edition=full","pubTime":"2024-11-20 01:01","pubTimestamp":1732035673,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日01时01分，Theriva Biologics, Inc.股票出现异动，股价快速上涨5.65%。截至发稿，该股报1.31美元/股，成交量5.9778万股，换手率2.15%，振幅4.84%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120010113971a77cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120010113971a77cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2484803679","title":"Theriva Biologics, Inc.盘中异动 急速上涨5.15%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484803679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484803679?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:32","pubTimestamp":1731940321,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时32分，Theriva Biologics, Inc.股票出现异动，股价急速拉升5.15%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Hcw Biologics Inc.、冠科美博、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为516.33%、194.37%、185.59%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Biomx Inc.，振幅分别为44.84%、31.28%、19.34%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822320198e433ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822320198e433ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2483580796","title":"Theriva Biologics, Inc.盘中异动 早盘大幅下跌5.63%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483580796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483580796?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:53","pubTimestamp":1731595992,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时53分，Theriva Biologics, Inc.股票出现异动，股价快速下挫5.63%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Pulmatrix, Inc.涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Pulmatrix, Inc.较为活跃，换手率分别为1968.64%、30.99%、26.61%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp C/Wts 24/02/2025、Pulmatrix, Inc.，振幅分别为75.00%、44.00%、38.76%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114225312abc16668&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114225312abc16668&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2483071864","title":"Theriva Biologics, Inc.2024财年第三财季实现净利润-7.73百万美元，同比减少134.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483071864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483071864?lang=zh_cn&edition=full","pubTime":"2024-11-14 08:02","pubTimestamp":1731542534,"startTime":"0","endTime":"0","summary":"11月14日，Theriva Biologics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-7.73百万美元，同比减少134.24%；其中营业收入为0.00美元，每股基本收益为-6.81美元。从资产负债表来看，Theriva Biologics, Inc.总负债15.47百万美元，其中短期债务606000.00美元，资产负债比为2.60，流动比率为2.67。机构评级：截至2024年11月14日，当前有2家机构对Theriva Biologics, Inc.目标价做出预测，其中目标均价为90.50美元，其中最低目标价为6.00美元，最高目标价为175.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080223abbee689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080223abbee689&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX"],"gpt_icon":0},{"id":"2483188453","title":"Theriva Biologics, Inc.盘中异动 早盘大幅上涨5.59%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483188453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483188453?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508308,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分，Theriva Biologics, Inc.股票出现异动，股价大幅拉升5.59%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Mersana Therapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为328.33%、171.14%、84.18%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Mersana Therapeutics, Inc.、Ginkgo Bioworks Holdings, Inc.，振幅分别为12.77%、9.00%、8.58%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322314895be2341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322314895be2341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2482763073","title":"Theriva Biologics, Inc.盘中异动 大幅下跌7.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482763073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482763073?lang=zh_cn&edition=full","pubTime":"2024-11-12 04:56","pubTimestamp":1731358607,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日04时56分，Theriva Biologics, Inc.股票出现波动，股价急速下跌7.54%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。其相关个股中，Cero Therapeutics Holdings, Inc.、Geovax Labs, Inc.、Aligos Therapeutics, Inc.涨幅较大，Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为942.90%、531.99%、342.87%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为132.14%、72.42%、65.93%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112045648a22d88da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112045648a22d88da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2481949100","title":"Theriva Biologics, Inc.盘中异动 早盘急速跳水6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481949100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481949100?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:06","pubTimestamp":1731078377,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时06分，Theriva Biologics, Inc.股票出现异动，股价急速下跌6.01%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108230617abae50fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108230617abae50fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2481987587","title":"Theriva Biologics, Inc.盘中异动 早盘股价大涨5.08%报2.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481987587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481987587?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:31","pubTimestamp":1730907082,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时31分，Theriva Biologics, Inc.股票出现异动，股价急速上涨5.08%。截至发稿，该股报2.07美元/股，成交量16.1394万股，换手率7.10%，振幅9.14%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106233122aba6d53e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106233122aba6d53e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":1},{"id":"2480581437","title":"Theriva Biologics, Inc.盘中异动 股价大跌6.03%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581437?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:31","pubTimestamp":1730730690,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时31分，Theriva Biologics, Inc.股票出现波动，股价大幅下挫6.03%。截至发稿，该股报1.87美元/股，成交量37.6298万股，换手率16.56%，振幅3.02%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422313095bdc9a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422313095bdc9a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2480105747","title":"Theriva Biologics, Inc.盘中异动 下午盘急速跳水5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480105747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480105747?lang=zh_cn&edition=full","pubTime":"2024-11-01 02:25","pubTimestamp":1730399142,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日02时25分，Theriva Biologics, Inc.股票出现波动，股价急速下跌5.39%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为3.45%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Evogene Ltd.、Gri Bio, Inc.较为活跃，换手率分别为272.45%、241.89%、196.44%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Vaccinex, Inc.、Promis Neurosciences Inc.，振幅分别为80.77%、47.15%、46.33%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110102254298e3fc82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110102254298e3fc82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2479923152","title":"Theriva Biologics, Inc.盘中异动 大幅下挫5.92%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479923152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479923152?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:59","pubTimestamp":1730221151,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时59分，Theriva Biologics, Inc.股票出现波动，股价快速下挫5.92%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Dermata Therapeutics Inc C/Wts 涨幅较大，Lixte Biotechnology Holdings, Inc.、Glycomimetics, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为1340.53%、1269.00%、331.45%，振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Dermata Therapeutics Inc C/Wts ，振幅分别为183.65%、88.24%、78.31%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000591198e3f287&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000591198e3f287&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.therivabio.com","stockEarnings":[{"period":"1week","weight":0.479},{"period":"1month","weight":0.375},{"period":"3month","weight":-0.2574},{"period":"6month","weight":-0.7104},{"period":"1year","weight":-0.8391},{"period":"ytd","weight":-0.8363}],"compareEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.0548},{"period":"6month","weight":0.1005},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.2651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Theriva Biologics, Inc.成立于1986年，是一家生物技术公司，专注于合成DNA为基础的疗法和治疗严重疾病的创新型疾病缓解药物的发展。该公司是一家多元化的临床阶段公司，开发旨在治疗高度未满足需求领域疾病的疗法。公司通过收购VCN Biosciences，SL进入肿瘤学领域，VCN Biosciences，SL开发了一种新的溶瘤腺病毒平台，设计用于静脉、玻璃体内和抗肿瘤递送以触发肿瘤细胞死亡，改善共同给药的癌症疗法对肿瘤的获取，并促进患者免疫系统产生强大而持续的抗肿瘤反应。","exchange":"AMEX","name":"Theriva Biologics","nameEN":"Theriva Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Theriva Biologics(TOVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Theriva Biologics(TOVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Theriva Biologics,TOVX,Theriva Biologics股票,Theriva Biologics股票老虎,Theriva Biologics股票老虎国际,Theriva Biologics行情,Theriva Biologics股票行情,Theriva Biologics股价,Theriva Biologics股市,Theriva Biologics股票价格,Theriva Biologics股票交易,Theriva Biologics股票购买,Theriva Biologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Theriva Biologics(TOVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Theriva Biologics(TOVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}